Patients Treated with Leksell Gamma Knife ® 1968-2014

Preview:

Citation preview

Patients Treated with Leksell Gamma Knife®

1968-2014

2

• Global Statistics Slide Number

Cumulative volume3

Indications treated annually 4 2014 regional volume

5 Average regional volume

6 Global case mix by year

7 Cumulative regional case mix 8 2014 case mix

9 Cumulative case mix

10 Cumulative indications treated 11 Indications treated 2014

12 Case mix by country

13 Indications fractionated 2014 43

• Indication-Specific Statistics

Vascular Disorders16

Functional Disorders21

Ocular Disorders 26 Benign Tumors

30 Malignant Tumors             

37

• Region & Country Statistics

Asia (excluding Japan) Cumulative volume

46 Indications treated annually 47 Cumulative case mix

48 Cumulative indications treated 49 2014 volume

50 China cumulative volume

51 China case mix

52 South Korea cumulative volume 53 South Korea case mix

54 Taiwan cumulative volume

55 Taiwan case mix

56

TABLE OF CONTENTS North America Cumulative volume

58 Indications treated annually 59 Cumulative case mix

60 Cumulative indications treated 61 2014 volume

62 United States cumulative volume 63 United States case mix

64

Japan Cumulative volume

66 Indications treated annually 67 Cumulative case mix

68 Cumulative indications treated 69 2014 volume

70

Latin America Cumulative volume

72 Indications treated annually 73 Cumulative case mix

74 Cumulative indications treated 75 2014 volume

76

Europe Cumulative volume

78 Indications treated annually 79 Cumulative case mix

80 Cumulative indications treated 81 2014 volume

82 Turkey cumulative volume

83 Turkey case mix

84 United Kingdom cumulative volume

85 United Kingdom case mix

86

Middle East & Africa Cumulative volume

88 Indications treated annually 89 Cumulative case mix

90 Cumulative indications treated 91 2014 volume

92

• Please note that making detailed year over year comparisons is not advised due to the annual variability in number of centers reporting. The percent of centers reporting has ranged from 68% to 100%. The rate for 2014 is 95%.

• Data for specific countries is only provided for those countries with 7 or more Gamma Knives.

• The Society has increasingly improved the specificity of indication-specific reporting to allow for a more refined representation of clinical practice. For example, Essential Tremor treatments were reported within 'Other Functional Disorders' prior to 2012, but separately for the past three years.

• Please reference the Leksell Gamma Knife® Society when using or distributing the data in this presentation and do not hesitate to contact the Secretariat for any questions regarding the data.

CAVEATS

3

Leksell Gamma Knife®

OVER 884,000 PATIENTS TREATED THROUGH 2014, WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

4

Leksell Gamma Knife®

INDICATIONS TREATED ANNUALLY THROUGH 2014, WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

5

Leksell Gamma Knife®

TOTAL NUMBER OF TREATMENTS BY REGION 2014

95% centers reporting

17.6321.070

21.536

2.950

12.448

18.608

6

Leksell Gamma Knife®

AVERAGE NUMBER OF PERFEXION TREATMENTS PER REGION AND CENTER 2014

AVERAGE NUMBER OF TREATMENTS PER CENTER WORLDWIDE:

293

US: 183Canada: 316

95% centers reporting

7

Leksell Gamma Knife®

GLOBAL CASE MIX BY YEAR

13%

27%

49%46

%38%

33%

36%34%

34%

40% 42% 45%48% 46

%45%

46%

46% 43

%

44%

43%

46%

45%

47% 43

%

44%

33%

31%38%

42% 41%42%

39%35%37%

34% 31% 33% 32% 33% 35% 35% 35% 35% 38% 39% 39% 39% 39% 40%51%

40%

27%22% 19% 18% 16% 14% 13% 12% 11% 11% 10% 11% 11% 11% 10% 10% 10% 11% 10% 10% 10% 10%

3% 1% 2%1%

2% 3%1%

4% 6% 8% 9% 8% 9% 9% 9% 9% 8% 8% 8% 8% 7%

1%7% 7% 7% 7% 7%

68-100% centers reporting1991 reflects cumulative numbers

8

Leksell Gamma Knife®

CASE MIX FOR 1991 – 2014 BY REGION

27%

16%

31%

15%

71%

7%

21%

30%

13%

15%

49%

7%

51%

5%

46%

6%

20%

2% 1%

41%

6% 1%

67%

4%

28%

16%

68-100% centers reporting1991 reflects cumulative numbers

9

Leksell Gamma Knife®

CASE MIX FOR 2014 BY REGION

29%

32%

76%

24% 17

%

57%

52%

49%

18%

47%

67%

25%

15%

11%

5%

19%

12% 4%

5%

6%

9%

5% 13

%

1%

1%

1%

95% centers reporting

10

Leksell Gamma Knife®

TREATMENTS BY INDICATION 1991 – 2014, WORLDWIDE

325.009

386.895

3.317

64.995

103.991

68-100% centers reporting1991 reflects cumulative numbers

11

Leksell Gamma Knife®

INDICATIONS TREATED 1991 – 2014, WORLDWIDE

*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

*

68-100% centers reporting1991 reflects cumulative numbers

12

Leksell Gamma Knife®

INDICATIONS TREATED 2014, WORLDWIDE

95% centers reporting

13

Leksell Gamma Knife®

CASE MIX BY COUNTRY 2014

CHINA JAPAN SOUTH KOREA

2%

95% centers reporting

14

Leksell Gamma Knife®

CASE MIX BY COUNTRY 2014

TAIWAN UNITED KINGDOM

2.2%

95% centers reporting

15

Leksell Gamma Knife®

CASE MIX BY COUNTRY 2014

UNITED STATES TURKEY

2%

95% centers reporting

16

Leksell Gamma Knife®

VASCULAR DISORDERS, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

17

Leksell Gamma Knife®

VASCULAR DISORDERS, CUMULATIVE PATIENTS TREATED WORLDWIDE

86.987

353

5.905

10.136

610

68-100% centers reporting1991 reflects cumulative numbers

18

Leksell Gamma Knife®

VASCULAR DISORDERS TREATED ANNUALLY, WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

19

5.352

Leksell Gamma Knife®

VASCULAR DISORDERS, PATIENTS TREATED 2014 WORLDWIDE

1.393

268172

4

2.4%

95% centers reporting

20

Leksell Gamma Knife®

ARTERIOVENOUS MALFORMATIONS, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

21

Leksell Gamma Knife®

FUNCTIONAL DISORDERS, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

22

Leksell Gamma Knife®

FUNCTIONAL DISORDERS, CUMULATIVE PATIENTS TREATED WORLDWIDE

56.617

2.824

2.110

1.531

787475

267105

8275

65

1823

103

*

68-100% centers reporting1991 reflects cumulative numbers

2.4%

*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

23

Leksell Gamma Knife®

FUNCTIONAL DISORDERS TREATED ANNUALLY, WORLDWIDE

*

68-100% centers reporting1991 reflects cumulative numbers

*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

24

Leksell Gamma Knife®

FUNCTIONAL DISORDERS, PATIENTS TREATED 2014 WORLDWIDE

4.468

195

1623834

3428

2721

126

14

2

95% centers reporting

25

Leksell Gamma Knife®

TRIGEMINAL NEURALGIA, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

26

Leksell Gamma Knife®

OCULAR DISORDERS, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

27

Leksell Gamma Knife®

OCULAR DISORDERS, CUMULATIVE PATIENTS TREATED WORLDWIDE

350

321

2.646

68-100% centers reporting1991 reflects cumulative numbers

28

Leksell Gamma Knife®

OCULAR DISORDERS TREATED ANNUALLY, WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

29

Leksell Gamma Knife®

OCULAR DISORDERS, PATIENTS TREATED 2014 WORLDWIDE

227

33

3

95% centers reporting

30

Leksell Gamma Knife®

BENIGN TUMORS, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

31

Leksell Gamma Knife®

BENIGN TUMORS, CUMULATIVE PATIENTS TREATED WORLDWIDE

125.760

85.32463.692

9.189

8.277

6.254

5.5275.194

3.9123.341

3.3112.869

1.985

12090

164

68-100% centers reporting1991 reflects cumulative numbers

1.9%

1.7%

32

Leksell Gamma Knife®

BENIGN TUMORS TREATED ANNUALLY, WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

33

Leksell Gamma Knife®

BENIGN TUMORS, PATIENTS TREATED 2014 WORLDWIDE

7.632

13.031

4.459

881

749

512422

396306

251237

164158

917045

1.7%

95% centers reporting

34

Leksell Gamma Knife®

MENINGIOMA, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

35

Leksell Gamma Knife®

VESTIBULAR SCHWANNOMA, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

36

Leksell Gamma Knife®

PITUITARY ADENOMAS, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

37

Leksell Gamma Knife®

MALIGNANT TUMORS, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

38

Leksell Gamma Knife®

MALIGNANT TUMORS, CUMULATIVE PATIENTS TREATED WORLDWIDE

386.895

250334

1.0792.032

13.055

35.141

68-100% centers reporting1991 reflects cumulative numbers

39

Leksell Gamma Knife®

MALIGNANT TUMORS TREATED ANNUALLY, WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

40

Leksell Gamma Knife®

MALIGNANT TUMORS, PATIENTS TREATED 2014 WORLDWIDE

29.405

3969

135184

985

1.530

95% centers reporting

41

Leksell Gamma Knife®

METASTATIC TUMOR, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

42

Leksell Gamma Knife®

GLIAL TUMOR, CUMULATIVE PATIENTS TREATED WORLDWIDE

68-100% centers reporting1991 reflects cumulative numbers

43

Leksell Gamma Knife®

INDICATIONS FRACTIONATED 2014, USING THE LEKSELL FRAME OR WITH EXTEND™

40

210

362

51 centers reporting

44

Leksell Gamma Knife®

INDICATIONS FRACTIONATED 2014, USING THE LEKSELL FRAME OR WITH EXTEND™

51 centers reporting

Asia excluding Japan1990 - 2014

PATIENTS TREATEDWITH LEKSELL GAMMA KNIFE®

46

Leksell Gamma Knife®

OVER 235,000 PATIENTS TREATED THROUGH 2014ASIA (excluding Japan)

68-100% centers reporting1991 reflects cumulative numbers

47

Leksell Gamma Knife®

INDICATIONS TREATED ANNUALLYASIA (excluding Japan)

68-100% centers reporting1991 reflects cumulative numbers

48

Leksell Gamma Knife®

CASE MIX 1991 - 2014ASIA (excluding Japan)

355

12.412

39.02364.698

120.246

68-100% centers reporting1991 reflects cumulative numbers

49

Leksell Gamma Knife®

INDICATIONS TREATED 1991 – 2014, ASIA (excluding Japan)

*

68-100% centers reporting1991 reflects cumulative numbers

*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

50

Leksell Gamma Knife®

CASE MIX 2014ASIA (excluding Japan)

21

1.120 11.103

3.127

6.165

100% centers reporting

51

Leksell Gamma Knife®

OVER 157,000 PATIENTS TREATED THROUGH 2014CHINA

68-100% centers reporting1991 reflects cumulative numbers

52

Leksell Gamma Knife®

CASE MIX 1991 - 2014CHINA

9.129

82.592

42.368

289

23.362

68-100% centers reporting1991 reflects cumulative numbers

53

Leksell Gamma Knife®

OVER 42,000 PATIENTS TREATED THROUGH 2014SOUTH KOREA

68-100% centers reporting1991 reflects cumulative numbers

54

Leksell Gamma Knife®

CASE MIX 1991 - 2014SOUTH KOREA

16.302

17.991

50

7.326

1.216

68-100% centers reporting1991 reflects cumulative numbers

55

Leksell Gamma Knife®

OVER 13,000 PATIENTS TREATED THROUGH 2014TAIWAN

68-100% centers reporting

56

Leksell Gamma Knife®

CASE MIX 1993 - 2014TAIWAN

1.055

3.034

12

6.549

2.981

68-100% centers reporting

57

North America1987 - 2014

PATIENTS TREATEDWITH LEKSELL GAMMA KNIFE®

58

Leksell Gamma Knife®

OVER 225,000 PATIENTS TREATED THROUGH 2014NORTH AMERICA

68-100% centers reporting1991 reflects cumulative numbers

59

Leksell Gamma Knife®

INDICATIONS TREATED ANNUALLYNORTH AMERICA

68-100% centers reporting1991 reflects cumulative numbers

60

Leksell Gamma Knife®

CASE MIX 1991 - 2014NORTH AMERICA

63.547

35.604

16.703109.738

128

68-100% centers reporting1991 reflects cumulative numbers

61

Leksell Gamma Knife®

INDICATIONS TREATED 1991 – 2014, NORTH AMERICA

*

68-100% centers reporting1991 reflects cumulative numbers

*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

62

Leksell Gamma Knife®

CASE MIX 2014NORTH AMERICA

4.444

2.372

766

10.03515

93% centers reporting

63

Leksell Gamma Knife®

OVER 215,000 PATIENTS TREATED THROUGH 2014UNITED STATES

68-100% centers reporting1991 reflects cumulative numbers

64

Leksell Gamma Knife®

CASE MIX 1991 - 2014UNITED STATES

59.999

34.002

106.26015.813

107

68-100% centers reporting1991 reflects cumulative numbers

65

Japan1990 - 2014

PATIENTS TREATEDWITH LEKSELL GAMMA KNIFE®

66

Leksell Gamma Knife®

OVER 210,000 PATIENTS TREATED THROUGH 2014JAPAN

68-100% centers reporting1991 reflects cumulative numbers

67

Leksell Gamma Knife®

INDICATIONS TREATED ANNUALLYJAPAN

68-100% centers reporting1991 reflects cumulative numbers

68

Leksell Gamma Knife®

CASE MIX 1991 - 2014JAPAN

4.930

15.366

107

41.423

150.456

2.3%

68-100% centers reporting1991 reflects cumulative numbers

69

Leksell Gamma Knife®

INDICATIONS TREATED 1991 – 2014, JAPAN

*

68-100% centers reporting1991 reflects cumulative numbers

*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

70

Leksell Gamma Knife®

CASE MIX 2014JAPAN

133

614

9

2.268

9.424

100% centers reporting

71

Latin America1985 - 2014

PATIENTS TREATEDWITH LEKSELL GAMMA KNIFE®

72

Leksell Gamma Knife®

OVER 5,500 PATIENTS TREATED THROUGH 2014LATIN AMERICA

68-100% centers reporting1991 reflects cumulative numbers

73

Leksell Gamma Knife®

INDICATIONS TREATED ANNUALLYLATIN AMERICA

68-100% centers reporting1991 reflects cumulative numbers

74

Leksell Gamma Knife®

CASE MIX 1991 - 2014LATIN AMERICA

1.744

1.217

60

2.376

358

68-100% centers reporting1991 reflects cumulative numbers

75

Leksell Gamma Knife®

INDICATIONS TREATED 1991 – 2014, LATIN AMERICA

*

68-100% centers reporting1991 reflects cumulative numbers

*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

76

Leksell Gamma Knife®

CASE MIX 2014LATIN AMERICA 261

205

8

498

98

90% centers reporting

77

Europe1968 - 2014

PATIENTS TREATEDWITH LEKSELL GAMMA KNIFE®

78

Leksell Gamma Knife®

OVER 180,000 PATIENTS TREATED THROUGH 2014EUROPE

68-100% centers reporting1991 reflects cumulative numbers

79

Leksell Gamma Knife®

INDICATIONS TREATED ANNUALLYEUROPE

68-100% centers reporting1991 reflects cumulative numbers

80

Leksell Gamma Knife®

CASE MIX 1991 - 2014EUROPE

28.507

10.940

85.375

58.392

2.642

68-100% centers reporting1991 reflects cumulative numbers

81

Leksell Gamma Knife®

INDICATIONS TREATED 1991 – 2014, EUROPE

*

68-100% centers reporting1991 reflects cumulative numbers

*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

82

Leksell Gamma Knife®

CASE MIX 2014EUROPE

2.128

1.178

9.129

5.968

205

93% centers reporting

83

Leksell Gamma Knife®

OVER 22,000 PATIENTS TREATED THROUGH 2014TURKEY

68-100% centers reporting

84

Leksell Gamma Knife®

CASE MIX 1997 - 2014TURKEY

492

5.059

72

12.419

4.218

68-100% centers reporting

85

Leksell Gamma Knife®

OVER 22,000 PATIENTS TREATED THROUGH 2014UNITED KINGDOM

68-100% centers reporting1991 reflects cumulative numbers

86

Leksell Gamma Knife®

CASE MIX 1991 - 2014UNITED KINGDOM

1.186

7.829

302

9.934

3.364

68-100% centers reporting1991 reflects cumulative numbers

87

Middle East & Africa1996 - 2014

PATIENTS TREATEDWITH LEKSELL GAMMA KNIFE®

88

Leksell Gamma Knife®

OVER 17,000 PATIENTS TREATED THROUGH 2014MIDDLE EAST & AFRICA

68-100% centers reporting

89

Leksell Gamma Knife®

INDICATIONS TREATED ANNUALLYMIDDLE EAST & AFRICA

68-100% centers reporting

90

Leksell Gamma Knife®

CASE MIX 1996 - 2014MIDDLE EAST & AFRICA 2.648

2.394

2512.042

748

68-100% centers reporting

91

Leksell Gamma Knife®

CUMULATIVE INDICATIONS 1996 – 2014, MIDDLE EAST & AFRICA

*

68-100% centers reporting*Essential Tremor treatments reported as Other Functional Disorders prior to 2012

92

Leksell Gamma Knife®

CASE MIX 2014MIDDLE EAST & AFRICA 494

349

5

1.962

140

88% centers reporting

Recommended